Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.
about
Republished: Respiratory microbiota: addressing clinical questions, informing clinical practiceThe application of ecological theory toward an understanding of the human microbiomeCystic fibrosis therapy: a community ecology perspectiveA novel microbiota stratification system predicts future exacerbations in bronchiectasisThe airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic managementCulture enriched molecular profiling of the cystic fibrosis airway microbiomeEvolutionary remodeling of global regulatory networks during long-term bacterial adaptation to human hosts.Microbiota present in cystic fibrosis lungs as revealed by whole genome sequencingThe role of the bacterial microbiome in lung diseaseAn integrative approach to understanding microbial diversity: from intracellular mechanisms to community structure.The effects of inhaled aztreonam on the cystic fibrosis lung microbiome.Polymicrobial airway bacterial communities in adult bronchiectasis patients.Comparative analyses of the bacterial microbiota of the human nostril and oropharynx.Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communitiesDisordered microbial communities in the upper respiratory tract of cigarette smokers.Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma.Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infectionsThe microbiome in pediatric cystic fibrosis patients: the role of shared environment suggests a window of intervention.In-depth characterization via complementing culture-independent approaches of the microbial community in an acidic hot spring of the Colombian Andes.Time between collection and storage significantly influences bacterial sequence composition in sputum samples from cystic fibrosis respiratory infectionsMicrobial diversity under extreme euxinia: Mahoney Lake, Canada.Polymicrobial challenges to Koch's postulates: ecological lessons from the bacterial vaginosis and cystic fibrosis microbiomes.Respiratory tract clinical sample selection for microbiota analysis in patients with pulmonary tuberculosis.Decade-long bacterial community dynamics in cystic fibrosis airways.Upper respiratory tract microbial communities, acute otitis media pathogens, and antibiotic use in healthy and sick childrenSerial analysis of the gut and respiratory microbiome in cystic fibrosis in infancy: interaction between intestinal and respiratory tracts and impact of nutritional exposuresThe adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbationsAnalysis of the cystic fibrosis lung microbiota via serial Illumina sequencing of bacterial 16S rRNA hypervariable regions.Determining the influence of environmental and patient specific factors on the polymicrobial communities of the cystic fibrosis airway.Clinical significance of microbial infection and adaptation in cystic fibrosis.Microbial communities of the upper respiratory tract and otitis media in children.Interpreting infective microbiota: the importance of an ecological perspective.Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbationsThe microbial community of the cystic fibrosis airway is disrupted in early life.Respiratory microbiota: addressing clinical questions, informing clinical practice.Abundant DNase I-sensitive bacterial DNA in healthy porcine lungs and its implications for the lung microbiomeDraft Genome Sequences of Seven Pseudomonas fluorescens Subclade III Strains Isolated from Cystic Fibrosis PatientsMicrobiota and metabolite profiling reveal specific alterations in bacterial community structure and environment in the cystic fibrosis airway during exacerbation.High individuality of respiratory bacterial communities in a large cohort of adult cystic fibrosis patients under continuous antibiotic treatment.Correlation of Aggregatibacter actinomycetemcomitans detection with clinical/immunoinflammatory profile of localized aggressive periodontitis using a 16S rRNA microarray method: a cross-sectional study.
P2860
Q26797508-10429C98-490C-453A-9F76-187B8B2A925FQ26825590-001BA89C-AAD7-4919-BF5E-B71805E297EEQ27015964-10CA7695-FA0F-462E-9AA8-937117CEE210Q28235177-126D88D8-872B-4D55-AC31-159A309CFF40Q28730299-91BE94BB-74B5-4F15-9FD4-B8FCDF88CF83Q28742049-B0B33278-418C-4A64-93A3-F1EDEC8E3BB0Q30539692-71F6A2A9-53B6-438A-91EA-2A86AD930937Q31152913-0839F7CB-D6E1-4613-8AE7-114D7B7F8AFCQ33554623-C1784AB7-4EED-4AB9-86C1-D21DC96F1438Q33615178-3711B7FE-C727-4700-8A20-31A2156BAE5DQ33644835-ECC0790C-35D7-4203-A50A-66724907CAFDQ33650443-83A1D1EF-A413-4796-8BC4-1488A6356118Q33677712-202F361A-2BBC-4B49-A8B3-7BF07237EA0AQ33768691-C9C5C2CC-C07D-45B7-83BD-403CDB6B6D5AQ33781228-50EBEED0-7699-4EF7-A359-787B3917334FQ33782854-43E851AD-C88E-46EB-83C3-57BA84B56118Q33786154-8DF11AE5-DC46-49EF-A759-01C389E38A55Q33960112-0E149823-8FF1-4617-A608-C2E21017BE31Q34030523-402AA22F-4B86-46C9-A669-252E7083A14AQ34058611-A2E106D3-446D-45F7-A59F-5F8DD89F5357Q34157460-D7E525C4-C161-4C24-AA26-F364990D238CQ34179233-A0814872-8265-4F1C-B45A-54C2CE0B68F4Q34182509-0E9F1508-B6A7-4B77-8DD1-E0E0BB82FB7EQ34209009-449C65BD-7953-4A21-BAB4-9BB35F8FFC15Q34323552-8CBD8328-E5BE-4A39-9289-91C31B918638Q34388328-07074F90-8B22-4556-9C93-92B973A60E8CQ34437958-5216D56E-30A8-42B0-8D6B-2EB9600B4D4EQ34440993-3A8591DC-0D0A-489A-B15E-229F960293B1Q34488114-AE28D71B-812B-4662-8A35-7F8D42812542Q34491552-F4ECF4FD-1656-4B34-93B9-5148F854C518Q34541225-12992A20-E010-42F6-A377-DBB8642D960BQ34677317-289FA574-DB9C-4DB6-996C-93D761FB8E9CQ34706914-8EE1FE2C-C0FD-4C93-97DC-CB265CFBC409Q34744222-2309F42F-D53D-4502-BE4E-C67D9EDDACDEQ34818539-D3AF4D8E-B094-432D-8386-1B846BCAA03DQ34843160-574EE02F-41EC-41B2-8F9E-625149814C30Q35056908-1EB8D33B-2370-4042-AED5-91815557C8DCQ35072759-B2CBB2AA-92FC-4A11-8C7A-BE45BD8ED81FQ35074619-8213D265-D942-4109-826D-332F1E163ED6Q35078522-6B5ED953-FC6A-4D51-99AB-92BCF6A80308
P2860
Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Relationship between cystic fi ...... cs and Pseudomonas aeruginosa.
@en
Relationship between cystic fi ...... cs and Pseudomonas aeruginosa.
@nl
type
label
Relationship between cystic fi ...... cs and Pseudomonas aeruginosa.
@en
Relationship between cystic fi ...... cs and Pseudomonas aeruginosa.
@nl
prefLabel
Relationship between cystic fi ...... cs and Pseudomonas aeruginosa.
@en
Relationship between cystic fi ...... cs and Pseudomonas aeruginosa.
@nl
P2093
P50
P921
P1476
Relationship between cystic fi ...... cs and Pseudomonas aeruginosa.
@en
P2093
Alixandra A Knapp
Brian A Maurer
Jessica L Green
Katherine P Lemon
Martin Allgaier
Roberto Kolter
Stephen Lory
Susan V Lynch
Thomas R Martin
P304
P356
10.1111/J.1462-2920.2010.02173.X
P577
2010-02-23T00:00:00Z